Testosterone undecanoate
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate | |
| Clinical data | |
| Pregnancy cat. | X (USA), Teratogenic effects |
| Legal status | Schedule III (USA) Schedule IV (Canada) |
| Routes | oral,I.V |
| Pharmacokinetic data | |
| Bioavailability | 7% |
| Metabolism | Liver, Testis and Prostate |
| Half-life | 1-12 days |
| Excretion | Urine |
| Identifiers | |
| CAS number | 5949-44-0 |
| ATC code | G03BA03 |
| PubChem | CID 65157 |
| ChemSpider | 23089522  |
| KEGG | D06087 |
| Chemical data | |
| Formula | C30H48O3 |
| Mol. mass | 456.70032 |
|
|
 (what is this?) (verify) |
|
Testosterone undecanoate or testosterone undecylate is an ester of testosterone. This hormone is used in androgen replacement therapy primarily for the treatment of male hypogonadism, and is currently under research for use as a male contraceptive. It is sold and distributed under the brand names Andriol, Undestor, Nebido, Pantestone, Restandol, Cernos Depot and Nebido-R and Reandron 1000.[1]
References [edit]
- ^ Köhn, FM; Schill, WB (Nov 2003). "A new oral testosterone undecanoate formulation.". World J Urol 21 (5): 311–5. doi:10.1007/s00345-003-0372-x. PMID 14579074.
External links [edit]
- testosterone undecanoate at the US National Library of Medicine Medical Subject Headings (MeSH)
|
||||||||||||||||||||||||||||||||||||||
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
